Not applicableStudy completedNCT01291485What this trial is testingElectronic Intervention for HIV Medication AdherenceWho this might be right forHIV Oklahoma State University Center for Health Sciences 97
Post-approval studies (Phase 4)Study completedNCT01761643What this trial is testingCCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSMWho this might be right forPatient AdherenceHIV Seronegativity University of California, San Diego 398
Not applicableStudy completedNCT01252537What this trial is testingImmunosuppression in HIV-infected Patients With Tuberculosis in EthiopiaWho this might be right forHIV InfectionTuberculosisImmunosuppression Lund University 1,200
Early research (Phase 1)Study completedNCT00435929What this trial is testingSaquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.Who this might be right forHIV Infections Hoffmann-La Roche 16
Not applicableStudy completedNCT00002069What this trial is testingDTC in Patients With AIDS and AIDS Related ComplexWho this might be right forHIV Infections Merieux Institute
Not applicableStudy completedNCT00002005What this trial is testingA Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related ComplexWho this might be right forHIV Infections Genentech, Inc.
Not applicableEnded earlyNCT00937729What this trial is testingProspective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active MoleculesWho this might be right forHIV1 InfectionHIV Infections University Hospital, Rouen 4
Not applicableStudy completedNCT05342337What this trial is testingExercise Therapy With Telerehabilitation in Patients Living With HIVWho this might be right forHIV Infections Hasan Kalyoncu University 55
Not applicableStudy completedNCT00014937What this trial is testingSimplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination RegimenWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 240
Large-scale testing (Phase 3)Study completedNCT00001022What this trial is testingA Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected PatientsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 1,200
Not applicableStudy completedNCT04810559What this trial is testingNear Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole BloodWho this might be right forHIV TestingHIV Infections Unity Health Toronto 600
Testing effectiveness (Phase 2)Study completedNCT00002079What this trial is testingPhase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)Who this might be right forHIV Infections G D Searle
Testing effectiveness (Phase 2)Study completedNCT00071890What this trial is testingPhase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral TxWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 148
Early research (Phase 1)Study completedNCT00000680What this trial is testingA Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARCWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 6
Not applicableStudy completedNCT03664440What this trial is testingEfficacy of Rilpivirine-based Regimens as Switch Therapy From Nevirapine-based Regimens in HIV-infected PatientsWho this might be right forEfficacy of Rilpivirine-based Regimens as Switch Therapy Mahidol University 106
Post-approval studies (Phase 4)Ended earlyNCT01367210What this trial is testingSwitch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)Who this might be right forHIV Infection Catholic University of the Sacred Heart 165
Testing effectiveness (Phase 2)Study completedNCT00000820What this trial is testingA Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral TherapyWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 104
Not applicableStudy completedNCT00016588What this trial is testingTenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV DrugsWho this might be right forHIV Infections Gilead Sciences
Post-approval studies (Phase 4)UnknownNCT02285374What this trial is testingEfavirenz to Dolutegravir Switch in Patients With CNS ToxicityWho this might be right forHIV St Stephens Aids Trust 40
Not applicableStudy completedNCT04813484What this trial is testingAddressing Violence and HIV Care Among Transgender WomenWho this might be right forAcceptability of Health CareHIV Infections University of Michigan 11